Gilberto Lopes, MD, MBA, FAMS

Articles by Gilberto Lopes, MD, MBA, FAMS

32 Impact of Comorbid HIV Infection on Breast Cancer Time to Treatment and Chemotherapy Relative Dose Intensity

ByElizabeth Rubin,Philippos Costa,Michael H. Antoni,Judith Hurley, MD,Gilberto Lopes, MD, MBA, FAMS,Danial S O’Neil

April 18th 2022

Gilberto Lopes, MD, MBA, FAMS, on Stopping Immunotherapy in Patients With Lung Cancer

ByGilberto Lopes, MD, MBA, FAMS

February 21st 2020

Gilberto Lopes, MD, MBA, FAMS, discussed his presentation about when to stop immunotherapy treatments for patients with lung cancer.

Latest Updated Articles

32 Impact of Comorbid HIV Infection on Breast Cancer Time to Treatment and Chemotherapy Relative Dose Intensity
April 18th 2022
Gilberto Lopes, MD, MBA, FAMS, on Stopping Immunotherapy in Patients With Lung Cancer
February 21st 2020

Trending on CancerNetwork

FDA Approves Tucatinib Combo as Maintenance in HER2+ Breast Cancer

Novel Cancer Vaccine Plus Temozolomide Miss Primary End Point in Glioblastoma

Personalized Vaccines May Have Utility Across All Lung Cancer Stages

Considering Talquetamab and Emerging Bispecifics in R/R Multiple Myeloma

Transmucosal Patch Yields Pathologic Responses in Non-Invasive Oral Cancer